Pro-Dex/$PDEX
1D1W1MYTD1Y5YMAX
Capital at risk
About Pro-Dex
Pro-Dex Inc is engaged in the design, development, manufacture, sale and repair of handheld medical devices and accessories, with products including Powered Surgical Drivers, Precision Air Powered Motors and others, including autoclavable, battery-powered and electric multi-function surgical drivers and shavers used mainly in the orthopedic, thoracic and craniomaxillofacial markets, as well as providing engineering, quality, regulatory consulting, NRE and prototype services, and manufacturing and selling rotary air motors and precision machined parts and assemblies for the aerospace and defense industries, with the majority of revenue derived from designing, developing, manufacturing and repairing powered surgical instruments for medical device original equipment manufacturers.
- Ticker
- $PDEX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 204
- Headquarters
- Irvine, United States
- Website
- www.pro-dex.com
Pro-Dex Metrics
BasicAdvanced
$232M
17.58
$4.12
0.06
-
Price and volume
Market cap
$232M
Beta
0.06
52-week high
$77.00
52-week low
$23.47
Average daily volume
72K
Financial strength
Current ratio
4.101
Quick ratio
2.401
Long term debt to equity
0.292
Total debt to equity
0.398
Interest coverage (TTM)
16.00%
Profitability
EBITDA (TTM)
14.385
Gross margin (TTM)
31.38%
Net profit margin (TTM)
17.62%
Operating margin (TTM)
16.75%
Effective tax rate (TTM)
24.16%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
11.97%
Return on equity (TTM)
32.43%
Valuation
Price to earnings (TTM)
17.575
Price to revenue (TTM)
3.012
Price to book
4.84
Price to tangible book (TTM)
5.71
Price to free cash flow (TTM)
34.559
Free cash flow yield (TTM)
2.89%
Free cash flow per share (TTM)
2.095
Growth
Revenue change (TTM)
16.45%
Earnings per share change (TTM)
54.31%
3-year revenue growth (CAGR)
18.94%
10-year revenue growth (CAGR)
14.99%
3-year earnings per share growth (CAGR)
28.32%
10-year earnings per share growth (CAGR)
35.43%
What the Analysts think about Pro-Dex
Majority rating from 1 analysts.
| Month | Buy | Hold | Sell | Analysts | Majority rating |
|---|---|---|---|---|---|
| November 2023 | 1 | 0 | 0 | 1 | Buy |
| December 2023 | 1 | 0 | 0 | 1 | Buy |
| January 2024 | 1 | 0 | 0 | 1 | Buy |
| February 2024 | 1 | 0 | 0 | 1 | Buy |
| March 2024 | 1 | 0 | 0 | 1 | Buy |
| April 2024 | 1 | 0 | 0 | 1 | Buy |
| May 2024 | 1 | 0 | 0 | 1 | Buy |
| June 2024 | 1 | 0 | 0 | 1 | Buy |
Upcoming events
No upcoming events
Funds containing Pro-Dex
Fund name | Fund size | $PDEX weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.